University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 3G-03-5


 
Description: Phase II Study of Irinotecan and Docetaxel in Patients with Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma.
Status: Open
Randomized? No


Researchers  
Principal InvestigatorTitle
Syma IqbalM.D.

Data Management
NameTitle
Ramona LujanR.N.
Noureddine MiloudD.M.
Mileidys GomezD.M.


You may participate in this study if:
(No criteria found)

You may not participate in this study if:
(No criteria found)

For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.